Alkion BioInnovations

About:

Alkion BioInnovations is a biotechnology company based in France.

Top Investors: Bpifrance, European Innovation Council, European Union, European Commission, WILCO

Description:

Alkion BioInnovations was created in March 2017 in order to develop disruptive cannabinoid & pharmaceutical API production using large scale plant tissue production. The team works also on a new sugar replacement: a novel plant-based high intensive protein sweetener. The company won many R&D grants: I-lab, I-Nov, Plan de Relance & EIC Phase I; and other prize: La Fabrique Aviva, Netva, Wilco, IPA4SME...

Total Funding Amount:

4.76M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulogne-billancourt, Ile-de-France, France

Founded Date:

2011-01-01

Contact Email:

franck.pradier(AT)alkinnov.com

Founders:

Franck Michoux, Franck Pradier, Govind Pindoria, Sarah Meryll Buet

Number of Employees:

11-50

Last Funding Date:

2022-06-07

IPO Status:

Private

Industries: